Regulatory PathRegulatory requirements compared

Active substances

Potassium chloride + Sodium chloride

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
0.075% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.075 %,%Solution for infusion · Intravenous use1 BagSAR 8.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.075% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.075 %,%Solution for infusion · Intravenous use1 BagSAR 18.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.15% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.15 %,%Solution for infusion · Intravenous use1 BagSAR 10.25Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.15% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.15 %,%Solution for infusion · Intravenous use1 BagSAR 18.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.22% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.22 %,%Solution for infusion · Intravenous use1 BagSAR 8.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.22% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP0.9,0.22 %,%Solution for infusion · Intravenous use1 BagSAR 18.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.3% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE USP0.9,0.3 %,%Solution for infusion · Intravenous use1 BagSAR 8.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.3% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE USP0.9,0.3 %,%Solution for infusion · Intravenous use1 BagSAR 18.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
0.6% w/v Potassium Chloride in 0.9% w/v Sodium Chloride Injection USP0.9,0.6 %,%Solution for infusion · Intravenous use1 BagSAR 18.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
Indications — CHI Daman Drug Formulary

FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%150MG/100ML;900MG/100MLinjectable · injectionBAXTER HLTHCAREPrescription2 Feb 1979
POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%300MG/100ML;900MG/100MLinjectable · injectionBAXTER HLTHCAREPrescription2 Feb 1979
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%150MG/100ML;450MG/100MLinjectable · injectionBAXTER HLTHCAREPrescription2 Feb 1979
POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER149MG/100ML;900MG/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription17 Oct 1988
POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER298MG/100ML;900MG/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription17 Oct 1988
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER150MG/100ML;900MG/100MLinjectable · injectionB BRAUNPrescription29 Sep 1989
POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER149MG/100ML;450MG/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription10 Sep 2008
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%150MG/100ML;450MG/100MLinjectable · injectionFRESENIUS KABI USAPrescription17 Sep 2020
POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%300MG/100ML;900MG/100MLinjectable · injectionFRESENIUS KABI USAPrescription17 Sep 2020
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%150MG/100ML;900MG/100MLinjectable · injectionFRESENIUS KABI USAPrescription17 Sep 2020
POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%224MG/100ML;900MG/100MLinjectable · injectionBAXTER HLTHCAREDiscontinued2 Feb 1979
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%75MG/100ML;900MG/100MLinjectable · injectionBAXTER HLTHCAREDiscontinued2 Feb 1979
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER75MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued9 Nov 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER150MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued9 Nov 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER220MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued9 Nov 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER300MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued9 Nov 1982
POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER37MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued29 Sep 1989
POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER75MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued29 Sep 1989
POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER110MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued29 Sep 1989
POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER220MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued29 Sep 1989
POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER300MG/100ML;900MG/100MLinjectable · injectionB BRAUNDiscontinued29 Sep 1989

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP00786209150 MG / 100 ML; 900 MG / 100 MLSOLUTION · INTRAVENOUSBAXTER CORPORATION
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP00786217900 MG / 100 ML; 300 MG / 100 MLLIQUID · INTRAVENOUSBAXTER CORPORATION
POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP02269414450 MG / 100 ML; 150 MG / 100 MLSOLUTION · INTRAVENOUSBAXTER CORPORATION

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.